Literature DB >> 16844954

Myelin protein zero mutation His39Pro: hereditary motor and sensory neuropathy with variable onset, hearing loss, restless legs and multiple sclerosis.

D H Kilfoyle1, P J Dyck, Y Wu, W J Litchy, D M Klein, P J B Dyck, N Kumar, J M Cunningham, C J Klein.   

Abstract

BACKGROUND: Mutations of myelin protein zero (MPZ) may cause inherited neuropathy with variable expression.
OBJECTIVE: To report phenotypic variability in a large American kindred with MPZ mutation His39Pro. PATIENTS: Genetic testing was performed on 77 family members and 200 controls. Clinical and electrophysiological field study assessments were available for review in 47 family members.
RESULTS: His39Pro was found in all 10 individuals prospectively identified with neuropathy. 200 normal controls were without mutation. Symptoms of neuropathy began in adulthood and were slowly progressive except for one acute-onset painful sensory neuropathy. Associated features included premature hearing loss (n = 7), nocturnal restless leg symptoms (n = 8) and multiple sclerosis in one.
CONCLUSIONS: MPZ mutation His39Pro may be associated with acute-onset neuropathy, early-onset hearing loss and restless legs. The relationship with multiple sclerosis in the proband remains uncertain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16844954      PMCID: PMC2077629          DOI: 10.1136/jnnp.2006.090076

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  24 in total

1.  The CNS phenotype of X-linked Charcot-Marie-Tooth disease: more than a peripheral problem.

Authors:  Robert A Taylor; Erin M Simon; Harold G Marks; Steven S Scherer
Journal:  Neurology       Date:  2003-12-09       Impact factor: 9.910

2.  Chronic cough due to Thr124Met mutation in the peripheral myelin protein zero (MPZ gene).

Authors:  Robert H Baloh; Joanna C Jen; Gilbert Kim; Robert W Baloh
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910

3.  Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study.

Authors:  Wayne Hening; Arthur S Walters; Richard P Allen; Jacques Montplaisir; Andrew Myers; Luigi Ferini-Strambi
Journal:  Sleep Med       Date:  2004-05       Impact factor: 3.492

4.  Central nervous system involvement in hereditary neuropathy with liability to pressure palsies: description of a large family with this association.

Authors:  Jordi Sanahuja; Elena Franco; Ricardo Rojas-García; Eduard Gallardo; Onofre Combarros; Robert Begué; Pilar Granés; Isabel Illa
Journal:  Arch Neurol       Date:  2005-12

5.  Bone marrow transfer from wild-type mice reverts the beneficial effect of genetically mediated immune deficiency in myelin mutants.

Authors:  M Mäurer; C D Schmid; F Bootz; J Zielasek; K V Toyka; S Oehen; R Martini
Journal:  Mol Cell Neurosci       Date:  2001-06       Impact factor: 4.314

6.  Marked phenotypic variation in a family with a new myelin protein zero mutation.

Authors:  A Szabo; S Züchner; E Siska; F Mechler; M J Molnar
Journal:  Neuromuscul Disord       Date:  2005-09-28       Impact factor: 4.296

7.  Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation.

Authors:  M Donaghy; S M Sisodiya; R Kennett; B McDonald; N Haites; C Bell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-12       Impact factor: 10.154

8.  Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury.

Authors:  J D Guest; E D Hiester; R P Bunge
Journal:  Exp Neurol       Date:  2005-04       Impact factor: 5.330

9.  Autonomic and respiratory dysfunction in Charcot-Marie-Tooth disease due to Thr124Met mutation in the myelin protein zero gene.

Authors:  T Stojkovic; J de Seze; O Dubourg; M C Arne-Bes; S Tardieu; J C Hache; P Vermersch
Journal:  Clin Neurophysiol       Date:  2003-09       Impact factor: 3.708

Review 10.  Phenotypic clustering in MPZ mutations.

Authors:  Michael E Shy; Agnes Jáni; Karen Krajewski; Marina Grandis; Richard A Lewis; Jun Li; Rosemary R Shy; Janne Balsamo; Jack Lilien; James Y Garbern; John Kamholz
Journal:  Brain       Date:  2004-01-07       Impact factor: 13.501

View more
  8 in total

Review 1.  Inherited neuropathies: clinical overview and update.

Authors:  Christopher J Klein; Xiaohui Duan; Michael E Shy
Journal:  Muscle Nerve       Date:  2013-06-26       Impact factor: 3.217

2.  Pegylated Insulin-Like Growth Factor 1 attenuates Hair Cell Loss and promotes Presynaptic Maintenance of Medial Olivocochlear Cholinergic Fibers in the Cochlea of the Progressive Motor Neuropathy Mouse.

Authors:  Linda Bieniussa; Baran Kahraman; Johannes Skornicka; Annemarie Schulte; Johannes Voelker; Sibylle Jablonka; Rudolf Hagen; Kristen Rak
Journal:  Front Neurol       Date:  2022-06-03       Impact factor: 4.086

3.  Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study.

Authors:  Mauro Manconi; Luigi Ferini-Strambi; Massimo Filippi; Enrica Bonanni; Alfonso Iudice; Luigi Murri; Gian Luigi Gigli; Lara Fratticci; Giovanni Merlino; Giovanni Terzano; Franco Granella; Liborio Parrino; Rosalia Silvestri; Irene Aricò; Vincenzo Dattola; Giovanna Russo; Carmela Luongo; Alessandro Cicolin; Antonella Tribolo; Paola Cavalla; Mariantonietta Savarese; Maria Trojano; Salvatore Ottaviano; Fabio Cirignotta; Valentina Simioni; Fabrizio Salvi; Fiorella Mondino; Franco Perla; Giorgia Chinaglia; Cristina Zuliani; Edward Cesnik; Enrico Granieri; Fabio Placidi; Maria Giuseppina Palmieri; Raffaele Manni; Michele Terzaghi; Roberto Bergamaschi; Raffaele Rocchi; Monica Ulivelli; Sabina Bartalini; Raffaele Ferri; Salvatore Lo Fermo; Emilio Ubiali; Massimo Viscardi; Mariarosa Rottoli; Lino Nobili; Alessandra Protti; Franco Ferrillo; Marta Allena; Gianluigi Mancardi; Biancamaria Guarnieri; Francesco Londrillo
Journal:  Sleep       Date:  2008-07       Impact factor: 5.849

Review 4.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

5.  Central Nervous System Demyelination in a Charcot-Marie-Tooth Type 1A Patient.

Authors:  Christos Koros; Maria-Eleftheria Evangelopoulos; Costas Kilidireas; Elisabeth Andreadou
Journal:  Case Rep Neurol Med       Date:  2013-12-16

6.  A Novel Asp121Asn Mutation of Myelin Protein Zero Is Associated with Late-Onset Axonal Charcot-Marie-Tooth Disease, Hearing Loss and Pupil Abnormalities.

Authors:  Xiaohui Duan; Weihong Gu; Ying Hao; Renbin Wang; Hong Wen; Shaojie Sun; Jinsong Jiao; Dongsheng Fan
Journal:  Front Aging Neurosci       Date:  2016-09-22       Impact factor: 5.750

7.  A rare association between multiple sclerosis and Charcot-Marie-Tooth type 1B.

Authors:  Rosa Cortese; Stefano Zoccolella; Maria Muglia; Alessandra Patitucci; Antonio Scarafino; Damiano Paolicelli; Isabella Laura Simone
Journal:  Brain Behav       Date:  2016-09-25       Impact factor: 2.708

8.  Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene.

Authors:  Oranee Sanmaneechai; Shawna Feely; Steven S Scherer; David N Herrmann; Joshua Burns; Francesco Muntoni; Jun Li; Carly E Siskind; John W Day; Matilde Laura; Charlotte J Sumner; Thomas E Lloyd; Sindhu Ramchandren; Rosemary R Shy; Tiffany Grider; Chelsea Bacon; Richard S Finkel; Sabrina W Yum; Isabella Moroni; Giuseppe Piscosquito; Davide Pareyson; Mary M Reilly; Michael E Shy
Journal:  Brain       Date:  2015-08-25       Impact factor: 13.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.